HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Benfield, J. R. Search for Related Content PubMed Articles by Benfield, J. R.

Ann Thorac Surg 1998;66:1451
© 1998 The Society of Thoracic Surgeons

---

Update

Invited commentary

^a Division of Cardiothoracic Surgery, University of California, Davis, 4301 X St, Suite 2250, Sacramento, CA 95817-2214, USA

Invited commentary

Doctor Dyke is probably correct that "... the seeming contrast between experimental and clinical data may lie in the varying degrees of myocardial injury." With the experimental data in favor of using triiodothyronine so strong, why not develop a cooperative trial into which many patients could be entered in a relatively short period of time? With standardized entry and evaluation criteria, and administration of triiodothyronine or pla-cebo by random choice, the clinical waters might become less murky.

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Benfield, J. R. Search for Related Content PubMed Articles by Benfield, J. R.